Summary
Target Corporation's Q3 2016 10-Q filing for the period ending October 29, 2016, shows a decline in sales primarily due to the divestiture of its pharmacy and clinic businesses in December 2015. Despite this, the company demonstrated improved profitability metrics compared to the prior year period, with GAAP diluted earnings per share from continuing operations increasing significantly. Key financial highlights include a strengthened gross margin rate and a reduced SG&A expense rate, contributing to an improved EBIT margin. The company continued its robust capital return program, repurchasing substantial amounts of stock and increasing dividends. While overall sales decreased, the performance within comparable sales and digital channel growth indicates underlying operational focus. The company also issued new long-term debt and managed its liquidity effectively, maintaining strong credit ratings.
Financial Highlights
46 data points| Revenue | $16.44B |
| Cost of Revenue | $11.54B |
| Gross Profit | $4.91B |
| SG&A Expenses | $3.34B |
| Operating Income | $1.06B |
| Interest Expense | $142.00M |
| Net Income | $608.00M |
| EPS (Basic) | $1.07 |
| EPS (Diluted) | $1.06 |
| Shares Outstanding (Basic) | 570.10M |
| Shares Outstanding (Diluted) | 574.80M |
Key Highlights
- 1Total sales decreased by 6.7% to $16,441 million in Q3 2016 compared to the prior year, largely attributed to the sale of the pharmacy and clinic businesses.
- 2Comparable sales saw a slight decline of 0.2%, driven by a 1.2% decrease in traffic, partially offset by a 1.0% increase in average transaction amount.
- 3Gross margin rate improved to 30.2% in Q3 2016 from 29.4% in Q3 2015, aided by product mix and cost savings, though offset by higher shipping costs.
- 4Selling, General & Administrative (SG&A) expense rate decreased to 20.3% from 20.7%, benefiting from the pharmacy transaction and technology cost savings.
- 5Diluted EPS from continuing operations significantly increased by 39.7% to $1.06 in Q3 2016.
- 6The company returned $1.2 billion to shareholders in Q3 2016 through dividends and share repurchases, with an ongoing $5 billion share repurchase program authorized.
- 7REDcard penetration increased to 24.3% of total sales in Q3 2016, up from 22.3% in the prior year period, indicating strong customer loyalty and engagement.